Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 960
| Issue Date | Title | Author(s) |
| 2024-08 | Design and synthesis of non-hydroxamate lipophilic inhibitors of 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR): in silico, in vitro and antibacterial studies | Sundriyal, Sandeep |
| 2024 | S-nitrosylation of EZH2 at C329 and C700 interplay with PRC2 complex assembly, methyltransferase activity, and EZH2 stability to regulate endothelial functions | Sundriyal, Sandeep; Chowdhury, Shibasish; Majumder, Syamantak |
| 2024 | Introduction to health informatics (hi): enhancing healthcare through information technology | Sundriyal, Sandeep |
| 2024-09 | Environmental sustainability and its impact on public health | Sundriyal, Sandeep |
| 2024-10 | Basic nitrogen (BaN): a ‘privileged element’ in medicinal chemistry | Sundriyal, Sandeep |
| 2024-11 | Unlocking the immunomodulatory potential of rosmarinic acid isolated from punica granatum l. Using bioactivity-guided approach: in silico, in vitro, and in vivo approaches | Sundriyal, Sandeep |
| 2025-01 | Multicomponent reactions (MCRs) yielding medicinally relevant rings: a recent update and chemical space analysis of the scaffolds | Sundriyal, Sandeep |
| 2025-01 | Design, synthesis and in vitro evaluation of primaquine and diaminoquinazoline hybrid molecules against the malaria parasite | Sundriyal, Sandeep |
| 2023-11 | Identification of synthetically tractable MERS-CoV main protease inhibitors using structure-based virtual screening and molecular dynamics potential of mean force (PMF) calculations | Sundriyal, Sandeep |
| 2025-01 | Development and experimental validation of a machine learning model for the prediction of new antimalarials | Sundriyal, Sandeep |
| 2024-06 | Resorption potential of endoflas powder with curcumin gel against endoflas for pulpectomy in primary mandibular molars: a one-year follow-up evidence-based case reports | Mahesh, Radhakrishnan |
| 2024-01 | Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics | Mahesh, Radhakrishnan |
| 2024-04 | Significance of LncRNAs in AKI-to-CKD transition: a therapeutic and diagnostic viewpoint | Gaikwad, Anil Bhanudas; Majumder, Syamantak |
| 2024-03 | Immunosuppressants against acute kidney injury: what to prefer or to avoid? | Gaikwad, Anil Bhanudas |
| 2024-06 | A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation | Gaikwad, Anil Bhanudas |
| 2024-07 | Targeting polo-like kinase 1 to treat kidney diseases | Gaikwad, Anil Bhanudas |
| 2024-08 | Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges | Gaikwad, Anil Bhanudas |
| 2024-11 | Apelinergic system in acute kidney injury: mechanistic insights and therapeutic potential | Gaikwad, Anil Bhanudas |
| 2024-08 | Acyl-coa synthetase long-chain isoenzymes in kidney diseases: mechanistic insights and therapeutic implications | Gaikwad, Anil Bhanudas |
| 2024-01 | Molecular insights into P2X signalling cascades in acute kidney injury | Gaikwad, Anil Bhanudas |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 960
